Lobby organisation
Illumina, Inc.
Business / industry · Health & pharma · HQ: United States · Transparency Register entry
As of 9 September 2026, Illumina, Inc. appears in 11 declared MEP meetings (10 different MEPs), most often with European People's Party.
In their own words
“Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 11 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (6 in 2025).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 11 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 28 Apr 2026 | Ingeborg ter Laak | Biotech Act |
| 10 Feb 2026 | Andreas Glück | MDR/IVDR Revision |
| 20 Jan 2026 | Michele Picaro | Meeting |
| 6 Oct 2025 | Letizia Moratti | Health policies |
| 25 Jun 2025 | Nicolás González Casares | Health |
| 24 Jun 2025 | Elena Nevado del Campo | Proyecto Genoma Europeo |
| 24 Jun 2025 | Waldemar Buda | Exchange views on how innovation in genomics can support the EU’s strategic priorities |
| 20 Mar 2025 | Oliver Schenk | Genom sequencing |
| 20 Mar 2025 | Stine Bosse | European health policy |
| 29 Oct 2024 | Stine Bosse | Rare diseases |
| 27 Jun 2023 | Tomislav Sokol | European Health Data Space - EHDS |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.